GlassScriptPhysician profile
Joshua Dworkin
NPI 1811247620
$22,609.91
in general payments reported to CMS, 2019-2025
9 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15K · 2023: $3,029 · 2024: $2,192 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,295 · Food and Beverage: $2,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,295.00 |
| Food and Beverage | $2,462.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $11,875.57 | 2022-2025 | |
| Mid-Atlantic Surgical Systems, LLC | $4,825.05 | 2022 | |
| Stryker Corporation | $1,878.78 | 2022-2025 | Actishield, Aequalis Perform, Aequalis Perform Reversed |
| Invictus Surgical Incorporated | $1,048.16 | 2025 | |
| Steelhead Surgical INC | $959.22 | 2023 | |
| Summit Surgical Corp. | $870.29 | 2023 | |
| Linvatec Corporation | $634.32 | 2025 | Biobrace 23mm, Linvatec Arthroscopy |
| Anika Therapeutics, INC. | $271.13 | 2024-2025 | Integrity, Integrity Implant, Tactoset |
| Depuy Synthes Sales INC. | $247.39 | 2024 | Fibergraft Aeridyan Matrix, Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Dworkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.